Hosken Consolidated Investments (JSE:HCI) Research & Development: R0 Mil (TTM As of Mar. 2026)


JSE:HCI Hosken Consolidated Investments Ltd JSE:HCI
73 GF Score
Price R161.50
GF Value R181.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Hosken Consolidated Investments Research & Development?

Hosken Consolidated Investments JSE:HCI -1.68% 73 Research & Development is R0 Mil as of Mar. 2026. GuruFocus rates JSE:HCI with a GF Score™ of 73/100 and a GF Value™ of R181.51 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Hosken Consolidated Investments's Research & Development for the six months ended in Mar. 2026 was R0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was R0 Mil.

Hosken Consolidated Investments  (JSE:HCI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hosken Consolidated Investments Research & Development Related Terms

Hosken Consolidated Investments Research & Development Historical Data

* Premium members only.

The historical data trend for Hosken Consolidated Investments's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hosken Consolidated Investments Research & Development Chart

Hosken Consolidated Investments Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hosken Consolidated Investments Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
JSE:HCI
73GF Score
Hosken Consolidated Investments Ltd JSE:HCI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hosken Consolidated Investments Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was R0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of R0 Mil mean?
Hosken Consolidated Investments (JSE:HCI) has a Research & Development of R0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Hosken Consolidated Investments and its competitors.
Is Hosken Consolidated Investments' Research & Development too high?
Hosken Consolidated Investments' current Research & Development is R0 Mil. Overall, Hosken Consolidated Investments has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hosken Consolidated Investments' Research & Development compare to HON and MMM?
Hosken Consolidated Investments' Research & Development of R0 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Conglomerates company?
A good Research & Development depends on the Conglomerates industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Hosken Consolidated Investments and its competitors. Hosken Consolidated Investments's current Research & Development is R0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hosken Consolidated Investments stock overvalued right now?
Based on GuruFocus' analysis, Hosken Consolidated Investments (JSE:HCI) is currently considered Modestly Undervalued. The stock's GF Value™ is R181.51, compared to a current price of R161.50 — trading 11% below its estimated fair value. The current Research & Development is R0 Mil. Hosken Consolidated Investments' overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Hosken Consolidated Investments (JSE:HCI), the current Research & Development is R0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hosken Consolidated Investments (JSE:HCI) Overvalued in 2026?

Based on GuruFocus' analysis, Hosken Consolidated Investments stock appears to be undervalued. The current stock price of R161.50 is trading 11% below its estimated GF Value™ of R181.51. GuruFocus considers Hosken Consolidated Investments to be Modestly Undervalued.

Key valuation signals for JSE:HCI:

  • Research & Development: R0 Mil
  • GF Value™: R181.51 vs. price of R161.50 (11% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the JSE:HCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hosken Consolidated Investments Business Description

Address 76 Regent Road, Suite 801, Sea Point, Cape Town, WC, ZAF, 8005
Hosken Consolidated Investments Ltd is an investment holdings company. The group is involved in a diverse group of investments including Media and broadcasting; Gaming; Transport; Properties; Coal mining; Branded products and manufacturing and other. It generates maximum revenue from the Branded products and manufacturing segment. Geographically, it operates in South Africa; Other African countries and Middle East; and Europe and United Kingdom.
73GF Score

Get the complete analysis for JSE:HCI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R161.50
Price
R181.51
GF Value